COMMUNIQUÉS West-GlobeNewswire

-
Cansortium Setting Up Shop in Casselberry, Growing Florida Footprint -- CFN Media
17/04/2019 -
SNOMED International’s Global Patient Set: Navigating International Patient Care and Interoperability
17/04/2019 -
Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
17/04/2019 -
Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean
17/04/2019 -
Allena Pharmaceuticals Appoints Allene Diaz to its Board of Directors
17/04/2019 -
VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs
17/04/2019 -
CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program
17/04/2019 -
Blissco Orders Additional High CBD Hemp Following Successful CBD Oil Extraction
17/04/2019 -
Radius Health to Present Two Posters at AACE 2019 Annual Meeting
17/04/2019 -
Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish M. Kamat to Its Scientific Board of Advisors
17/04/2019 -
Inovalon Announces First Quarter 2019 Earnings Conference Call
17/04/2019 -
Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer
17/04/2019 -
Intensity Therapeutics Receives Fast Track Designation from U.S. FDA for Development of INT230-6 as Treatment for Relapsed or Metastatic Triple Negative Breast Cancer
17/04/2019 -
Spark Therapeutics Announces Sponsorship of Believe Limited’s First-Ever Science Fair for the Hemophilia Community at 2019 National Hemophilia Foundation’s Bleeding Disorders Conference
17/04/2019 -
Radient Technologies Inc. Appoints Two New Members to its Board of Directors
17/04/2019 -
Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch -- CFN Media
17/04/2019 -
ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections
17/04/2019 -
Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
17/04/2019 -
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer
17/04/2019
Pages